|
|
The genetics of Beh?et’s disease in a Chinese population |
Shengping Hou1,2, Aize Kijlstra3, Peizeng Yang1,2() |
1. The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; 2. Chongqing Eye Institute and Chongqing Key Laboratory of Ophthalmology, Chongqing 400016, China; 3. University Eye Clinic Maastricht, Maastricht, Limburg, the Netherlands |
|
|
Abstract Beh?et’s disease is defined as a multisystemic inflammatory disease. Although the precise pathogenesis and etiology is still a mystery, accumulating evidence shows that genetic variants of immune-related genes have a profound influence on the development of Beh?et’s disease. To explore the genetic factors for Beh?et’s disease, our group investigated the association of Beh?et’s disease with multiple immune response genes and has identified multiple Beh?et’s disease-related immunoregulatory pathways in the Chinese Han population. A large number of gene polymorphisms were studied including STAT4, IL23R, CD40, CCR1/CCR3, STAT3, OPN, IL17, JAK2, MCP-1, CTLA4, PD-1, PD-L1, PD-L2, TGRBR3, CCR6, PTPN22, FCRL3, IRF5, SUMO4 and UBAC2. Significant associations were found between Beh?et’s disease and STAT4, IL23R, CD40, CCR1/CCR3, STAT3, MCP-1, TGFBR3, FCRL3, SUMO4, UBAC2. These genetic predisposition studies support an important role for both lymphocyte differentiation as well as ubiquitination pathways. These findings are helpful in elucidating the pathogenesis of Beh?et’s disease and hopefully will allow the development of novel treatment regimes.
|
Keywords
Beh?et’s disease
SNPs
immune gene
genetic study
|
Corresponding Author(s):
Yang Peizeng,Email:peizengycmu@126.com
|
Issue Date: 05 December 2012
|
|
1 |
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359(26): 2767-2777 doi: 10.1056/NEJMoa0807917 pmid:19073967
|
2 |
Evereklioglu C. Current concepts in the etiology and treatment of Beh?et disease. Surv Ophthalmol 2005; 50(4): 297-350 doi: 10.1016/j.survophthal.2005.04.009 pmid:15967189
|
3 |
James DG. Silk Route disease. Postgrad Med J 1986; 62(725): 151-153 doi: 10.1136/pgmj.62.725.151 pmid:3714598
|
4 |
Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M. Comparison of patients with Beh?et’s disease in the 1980s and 1990s. Ophthalmology 2004; 111(4): 810-815 doi: 10.1016/j.ophtha.2003.07.018 pmid:15051217
|
5 |
Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, Zhu L, Ren Y, Klooster J, Kijlstra A. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30(11): 943-948 doi: 10.1080/02713680500263606 pmid:16282128
|
6 |
Escudier M, Bagan J, Scully C. Number VII Beh?et’s disease (Adamantiades syndrome). Oral Dis 2006; 12(2): 78-84 doi: 10.1111/j.1601-0825.2005.01144.x pmid:16476027
|
7 |
Azizlerli G, K?se AA, Sarica R, Gül A, Tutkun IT, Kula? M, Tun? R, Urgancio?lu M, Di??i R. Prevalence of Beh?et’s disease in Istanbul, Turkey. Int J Dermatol 2003; 42(10): 803-806 doi: 10.1046/j.1365-4362.2003.01893.x pmid:14521694
|
8 |
Gül A. Beh?et’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005; 4(1): 81-83 doi: 10.2174/1568010053622894 pmid:15720240
|
9 |
Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Beh?et's disease. Clin Immunol 2008; 129(1):170-175 pmid:18657476
|
10 |
de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Beh?et’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61(10): 1287-1296 doi: 10.1002/art.24642 pmid:19790126
|
11 |
Krause L, K?hler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH. Ocular involvement is associated with HLA-B51 in Adamantiades-Beh?et’s disease. Eye (Lond) 2009; 23(5): 1182-1186 doi: 10.1038/eye.2008.177 pmid:18551141
|
12 |
Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. Evidence for linkage of the HLA-B locus in Beh?et’s disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44(1): 239-240 doi: 10.1002/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X pmid:11212166
|
13 |
Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Shiina T, Nomura E, Onari K, Ohno S, Inoko H. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Beh?et’s disease. Tissue Antigens 2001; 58(3): 181-184 doi: 10.1034/j.1399-0039.2001.580306.x pmid:11703826
|
14 |
Li H, Yang P, Jiang Z, Hou S, Xie L. Lack of association of two polymorphisms of IRF5 with Beh?et’s disease. Mol Vis 2009; 15: 2018-2021 pmid:19816589
|
15 |
Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, Frank SG, Reams E, Brown EE, Gibson AW, Marion MC, Langefeld CD, Li QZ, Karp DR, Wakeland EK, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Alarcón GS, Kimberly RP, Harley JB, Edberg JC. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008; 9(3): 187-194 doi: 10.1038/gene.2008.4 pmid:18288123
|
16 |
Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syv?nen AC. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 2007; 16(24): 3008-3016 doi: 10.1093/hmg/ddm259 pmid:17881657
|
17 |
Rueda B, Reddy MV, González-Gay MA, Balsa A, Pascual-Salcedo D, Petersson IF, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, González-Escribano MF, Alarcón-Riquelme ME, Martín J. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum 2006; 54(12): 3815-3819 doi: 10.1002/art.22271 pmid:17133578
|
18 |
Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ, Koivisto K, Elovaara I, Pirttil? T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syv?nen AC. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45(6): 362-369 doi: 10.1136/jmg.2007.055012 pmid:18285424
|
19 |
Zhang Q, Hou S, Jiang Z, Du L, Li F, Xiao X, Kijlstra A, Yang P. No association of PTPN22 polymorphisms with susceptibility to ocular Beh?et’s disease in two Chinese Han populations. PLoS ONE 2012; 7(3): e31230 doi: 10.1371/journal.pone.0031230 pmid:22396730
|
20 |
Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR. The association of the PTPN22 620W polymorphism with Beh?et’s disease. Ann Rheum Dis 2007; 66(11): 1531-1533 doi: 10.1136/ard.2007.073866 pmid:17660222
|
21 |
Du L, Yang P, Hou S, Zhou H, Kijlstra A. No association of CTLA-4 polymorphisms with susceptibility to Beh?et disease. Br J Ophthalmol 2009; 93(10): 1378-1381 doi: 10.1136/bjo.2008.156919 pmid:19570770
|
22 |
Zhang YJ, Xu WD, Duan ZH, Liu SS, Pan HF, Ye DQ.Lack of association between CTLA-4+49A/G and -318C/T polymorphisms and Beh?et's disease risk: a meta-analysis. Clin Exp Rheumatol 2012Sep25. [Epub ahead of print] pmid:23010350
|
23 |
Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens 2008; 72(1): 49-53 doi: 10.1111/j.1399-0039.2008.01062.x pmid:18498289
|
24 |
Ben Dhifallah I, Chelbi H, Braham A, Hamzaoui K, Houman MH. CTLA-4+49A/G polymorphism is associated with Beh?et’s disease in a Tunisian population. Tissue Antigens 2009; 73(3): 213-217 doi: 10.1111/j.1399-0039.2008.01186.x pmid:19254250
|
25 |
Xu Y, Song G. The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci 2004; 11(4): 426-438 doi: 10.1007/BF02256091 pmid:15153777
|
26 |
Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, Rosenbaum JT, Yang P. CD40 gene polymorphisms confer risk of Beh?et’s disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatology (Oxford) 2012; 51(1): 47-51 doi: 10.1093/rheumatology/ker345 pmid:22087016
|
27 |
Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AH, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TW, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40(10): 1216-1223 doi: 10.1038/ng.233 pmid:18794853
|
28 |
Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26(1): 677-704 doi: 10.1146/annurev.immunol.26.021607.090331 pmid:18173375
|
29 |
Meng Q, Guo H, Hou S, Jiang Z, Kijlstra A, Yang P. Lack of an association of PD-1 and its ligand genes with Beh?et’s disease in a Chinese Han population. PLoS ONE 2011; 6(10): e25345 doi: 10.1371/journal.pone.0025345 pmid:22039410
|
30 |
Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcón-Riquelme M, Lau YL. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005; 52(4): 1058-1062 doi: 10.1002/art.20966 pmid:15818672
|
31 |
Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, M?urer M, Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005; 58(1): 50-57 doi: 10.1002/ana.20514 pmid:15912506
|
32 |
Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gr?ndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, J?nssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32(4): 666-669 doi: 10.1038/ng1020 pmid:12402038
|
33 |
Di Marzio P, Dai WW, Franchin G, Chan AY, Symons M, Sherry B. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem Biophys Res Commun 2005; 331(4): 909-916 doi: 10.1016/j.bbrc.2005.04.015 pmid:15882964
|
34 |
Saeki T, Naya A. CCR1 chemokine receptor antagonist. Curr Pharm Des 2003; 9(15): 1201-1208 doi: 10.2174/1381612033454937 pmid:12769747
|
35 |
Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol 2001; 25(6): 707-716 pmid:11726396
|
36 |
Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Beh?et’s disease susceptibility. Hum Genet 2012Jul25. [Epub ahead of print] doi: 10.1007/s00439-012-1200-4 pmid:10.1007/s00439-012-1200-422829007" target="blank"> doi: 10.1007/s00439-012-1200-422829007
|
37 |
Kirino Y, Bertsias G, Ombrello MJ, Ustek D, Satorius C, Le J, Mizuki N, Ishigatsubo Y, Seyahi E, Sacli FS, Gul A, Kastner DL, Remmers E.Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Beh?et's Disease. Arthritis Rheum 2011; 63(10): S946
|
38 |
Hu K, Yang P, Jiang Z, Hou S, Du L, Li F. STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Beh?et’s disease. Hum Immunol 2010; 71(7): 723-726 doi: 10.1016/j.humimm.2010.04.007 pmid:20438790
|
39 |
Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R , Kijlstra A, Rosenbaum JT, Yang P. Genome-wide association study identifies susceptible locus in STAT4 for Beh?et's disease in Han Chinese. Arthritis Rheum 2012Sep22.[Epub ahead of print] doi: 10.1002/art.37708 pmid:.23001997
|
40 |
Chu M, Yang P, Hou S, Li F, Chen Y, Kijlstra A. Beh?et’s disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Hum Immunol 2011; 72(6): 525-529 doi: 10.1016/j.humimm.2011.03.016 pmid:21513757
|
41 |
Jiang Z, Yang P, Hou S, Du L, Xie L, Zhou H, Kijlstra A. IL-23R gene confers susceptibility to Beh?et’s disease in a Chinese Han population. Ann Rheum Dis 2010; 69(7): 1325-1328 doi: 10.1136/ard.2009.119420 pmid:20375120
|
42 |
Hu K, Hou S, Jiang Z, Kijlstra A, Yang P. JAK2 and STAT3 polymorphisms in a Han Chinese population with Beh?et’s disease. Invest Ophthalmol Vis Sci 2012; 53(1): 538-541 doi: 10.1167/iovs.11-8440 pmid:22205606
|
43 |
Shu Q, Yang P, Hou S, Li F, Chen Y, Du L, Jiang Z. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Beh?et’s disease in a Chinese Han population. Hum Immunol 2010; 71(10): 988-991 doi: 10.1016/j.humimm.2010.06.020 pmid:20620187
|
44 |
Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh?et’s disease susceptibility loci. Nat Genet 2010; 42(8): 703-706 doi: 10.1038/ng.624 pmid:20622879
|
45 |
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O’Shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh?et’s disease. Nat Genet 2010; 42(8): 698-702 doi: 10.1038/ng.625 pmid:20622878
|
46 |
Hou S, Yang P, Du L, Jiang Z, Mao L, Shu Q, Zhou H, Kijlstra A. Monocyte chemoattractant protein-1-2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Beh?et’s disease. Hum Immunol 2010; 71(1): 79-82 doi: 10.1016/j.humimm.2009.09.354 pmid:19782713
|
47 |
Yi X, Yang P, Du L, Jiang Z, Li F. There is no association of CCR6 polymorphisms with susceptibility to Beh?et’s disease in two Chinese Han populations. Br J Ophthalmol 2011; 95(11): 1603-1606 doi: 10.1136/bjophthalmol-2011-300018 pmid:21873313
|
48 |
Chen Y, Yang P, Li F, Hou S, Jiang Z, Shu Q, Kijlstra A. Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Beh?et’s disease in the Chinese Han population. Curr Eye Res 2012; 37(4): 312-317 doi: 10.3109/02713683.2011.635398 pmid:22440163
|
49 |
Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Beh?et’s disease using a genome-wide association study. Arthritis Res Ther 2009; 11(3): R66 doi: 10.1186/ar2695 pmid:19442274
|
50 |
Hou S, Shu Q, Jiang Z, Chen Y, Li F, Chen F, Kijlstra A, Yang P. Replication study confirms the association between UBAC2 and Beh?et’s disease in two independent Chinese sets of patients and controls. Arthritis Res Ther 2012; 14(2): R70 doi: 10.1186/ar3789 pmid:22455605
|
51 |
Sawalha AH, Hughes T, Nadig A, Y?lmaz V, Aksu K, Keser G, Cefle A, Yaz?c? A, Ergen A, Alarcón-Riquelme ME, Salvarani C, Casali B, Direskeneli H, Saruhan-Direskeneli G. A putative functional variant within the UBAC2 gene is associated with increased risk of Beh?et’s disease. Arthritis Rheum 2011; 63(11): 3607-3612 doi: 10.1002/art.30604 pmid:21918955
|
52 |
Fakhfakh Karray E, Bendhifallah I, Zakraoui L, Hamzaoui K. Association of small ubiquitin-like modifier 4 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Clin Exp Rheumatol 2011; 29(4): 751 pmid:21906435
|
53 |
Park G, Kim HS, Choe JY, Kim SK. SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Beh?et’s disease. Rheumatol Int 2012 ;32(10):3031-3037 pmid:21901353
|
54 |
.Li K, Zhao M, Hou S, Du L, Kijlstra A, Yang P. Association between polymorphisms of FCRL3, a non-HLA gene, and Beh?et’s disease in a Chinese population with ophthalmic manifestations. Mol Vis 2008; 14: 2136-2142 pmid:19050767
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|